The Valley Desk

NCT02675465 · Interventional trial

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Overall registry status Completed

Phase 1 · Phase 2

Conditions Pompe Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov